Archive for ◊ November, 2013 ◊

• Saturday, November 30th, 2013

Scion Biomedical sues board member and interim chief strategy and operating officer Allison London Brown, accusing her and the medical device startup she founded, Aegis Women’s Health Technology, of poaching trade secrets for its chitosan-based hemostasis products. Scion Biomedical sued board member and interim chief strategy and operating officer Allison London Brown, accusing her of […]

• Friday, November 29th, 2013

COLUMBIA — More than $1 million of tax credits have been granted to a biotech start-up in Columbia. Nanova Biomaterials Inc., a biotechnology company still in its early stage, plans to expand to a new building in north Columbia, purchase new equipments and make renovations, company President Han Li said. The company received $7 million […]

• Thursday, November 28th, 2013

Valeant Pharmaceuticals International Inc. will make its silicone hydrogel contact lenses in Rochester rather than in Ireland as originally planned, investing $106 million at Bausch & Lomb Inc.’s manufacturing facility here and adding 100 jobs, officials announced Monday. The work will bring $100 million in new investment into the Rochester economy and retain 1,050 jobs […]

• Wednesday, November 27th, 2013

Sitoa Global Announces Exclusive Letter of Intent With UC San Francisco, New Business Strategy and Corporate Restructuring HONG KONG, CHINA–(Marketwired – Nov 25, 2013) – Sitoa Global Inc. (“Sitoa Global”, or “the Company”) (OTCQB: STOA) announced today that it entered into an exclusive letter of intent (“LOI”) with the University of California, San Francisco (“UCSF”) […]

• Wednesday, November 27th, 2013

23andMe Inc., the Google Inc.-backed DNA analysis company co-founded by Anne Wojcicki, was told by U.S. regulators to halt sales of its main product because it’s being sold without “marketing clearance or approval.” Machines in the 23andMe labs, which provides genetic information to consumers. Photographer: Brent Humphreys/Redux The Saliva Collection Kit and Personal Genome Service, or PGS, […]

• Tuesday, November 26th, 2013

Boston Scientific Receives FDA Approval For Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System NATICK, Mass., Nov. 25, 2013 /PRNewswire/ — Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System, the company’s next-generation durable […]

• Tuesday, November 26th, 2013

Pixium Vision raises €15 million led by Sofinnova Partners PARIS, November 25, 2013 /PRNewswire/ — Funds to advance development of retinal implant systems that aim to restore vision in blind people Financing includes Bpifrance, through the InnoBio fund Pixium Vision (“Pixium”), a developer of innovative retinal implant systems that aim to restore vision in the […]

• Monday, November 25th, 2013

A staggering 80% of pharmaceutical and healthcare professionals now access work documents on the go. Yet in the absence of a safe file sharing alternative, 90% are resorting to unauthorized, free file sharing services, according to a new report released by Workshare. The report titled “Workforce Mobilization” is based on more than 5,000 responses from a range […]

• Sunday, November 24th, 2013

Hillsborough County isn’t yet ready to close the books on a happy and hectic year of job announcements. Covidien, a $10 billion health care company based in Massachusetts, said it is opening a medical device manufacturing facility in Hillsborough, creating up to 165 new jobs. Under the project detailed Thursday, Covidien pledged an $18 million […]

• Saturday, November 23rd, 2013

A New Jersey judge warned of several “rogue websites” by lawyers seeking to take advantage of Johnson & Johnson (JNJ)’s agreement to pay at least $2.47 billion to settle thousands of lawsuits over its recalled hip implants. Superior Court Judge Brian Martinotti heard a summary in Hackensack today of the settlement from lawyers who negotiated an […]